Allogene Therapeutics Inc (ALLO)
R&D Expenses
$122.52M
TTM · Period ending: · USD
ALLO R&D Expenses
Latest reported$122.52Mperiod ending
Latest reported$122.52Mperiod ending
ALLO TTM R&D Expenses ($151.86M → $122.52M)
TTM R&D Expenses
High-resolution chart · PNG
ALLO r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 122,520,000 | |
| 131,955,000 | |
| 150,152,000 | |
| 166,492,000 | |
| 180,041,000 | |
| 190,240,000 | |
| 192,299,000 | |
| 201,988,000 | |
| 203,252,000 | |
| 214,935,000 | |
| 242,914,000 | |
| 263,672,000 | |
| 281,336,000 | |
| 276,469,000 | |
| 256,387,000 | |
| 234,951,000 | |
| 230,030,000 | |
| 225,149,000 | |
| 220,176,000 | |
| 218,421,000 | |
| 211,122,000 | |
| 206,128,000 | |
| 192,987,000 | |
| 190,122,000 | |
| 178,696,000 | |
| 163,174,000 | |
| 144,535,000 | |
| 113,676,000 | |
| 84,551,000 | |
| 175,263,000 | |
| 151,860,000 | |
| 133,356,000 |